PEXIDARTINIB for Malignant connective tissue neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 19 adverse event reports in the FDA FAERS database where PEXIDARTINIB was used for Malignant connective tissue neoplasm.

Most Reported Side Effects for PEXIDARTINIB

Side Effect	Reports	%	Deaths	Hosp.
Fatigue	378	39.0%	3	38
Product dose omission issue	335	34.5%	3	30
Hair colour changes	327	33.7%	1	27
Nausea	213	22.0%	2	25
Pruritus	186	19.2%	0	10
Aspartate aminotransferase increased	134	13.8%	3	21
Rash	131	13.5%	2	12
Off label use	130	13.4%	6	16
Alanine aminotransferase increased	124	12.8%	1	20
Diarrhoea	106	10.9%	3	12
Headache	103	10.6%	0	11
Pain	100	10.3%	1	15
Arthralgia	94	9.7%	0	13
Therapy cessation	94	9.7%	2	6
Product dose omission in error	86	8.9%	0	7